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(57)	 ABSTRACT
Real time cardiac electrical data are received from a patient,
manipulated to determine various useful aspects of the ECG
signal, and displayed in real time in a useful form on a com-
puter screen or monitor. The monitor displays the high fre-
quency data from the QRS complex in units of microvolts,
juxtaposed with a display of conventional ECG data in units
of millivolts or microvolts. The high frequency data are ana-
lyzed for their root mean square (RMS) voltage values and the
discrete RMS values and related parameters are displayed in
real time. The high frequency data from the QRS complex are
analyzed with imbedded algorithms to determine the pres-
ence or absence of reduced amplitude zones, referred to
herein as "RAZs". RAZs are displayed as "go, no-go" signals
on the computer monitor. The RMS and related values of the
high frequency components are displayed as time varying
signals, and the presence or absence of RAZs may be simi-
larly displayed over time.
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1
REAL-TIME, HIGH FREQUENCY QRS
ELECTROCARDIOGRAPH WITH REDUCED
AMPLITUDE ZONE DETECTION
This application is a continuation of prior application Ser.
No. 09/906,013, filed Jul. 12, 2001, now U.S. Pat. No. 7,113,
820.
The invention described herein was made by employees of
the United States Government and may be manufactured and
used by or for the government for government purposes with-
out payment of any royalties thereon or therefore.
FIELD OF THE INVENTION
The present invention relates generally to the field of elec-
trocardiography, and more particularly to a real-time process-
ing system and method to analyze and display electrocardio-
graphic signals.
BACKGROUND OF THE INVENTION
Diagnosis of abnormal cardiac conditions has relied in the
past on visible alterations in the P, QRS, and T-waves, i.e.
portions of the electrocardiograph periodic signal. The elec-
trocardiograph signal includes a low frequency portion and an
impressed or imbedded high frequency portion, and it has
been found that although the higher frequency portion of the
signal is not particularly visible, it contains information that
provides greater sensitivity in determining certain abnormali-
ties, notably myocardial ischemia and infarction.
The conventional electrocardiogram (ECG) can be a very
insensitive diagnostic tool. For example, a significant per-
centage of individuals presenting to a hospital emergency
room with an actual myocardial infarction (heart attack) will
have a normal 12-lead conventional ECG. In addition, the
conventional ECG accurately reflects only the predominant
low-frequency electrical activity of the heart. It tells the cli-
nician little or nothing about the less predominant high fre-
quency components of the heart's electrical signal embedded
within the various lower-frequency waves of the conventional
ECG.
From off-line studies, it is known that a diminution of the
higher frequency components within the central portion of
the QRS complex of the ECG can be a highly sensitive indi-
cator for the presence of myocardial ischemia or infarction,
more sensitive, for example, than changes in the ST segment
of the conventional low-frequency electrocardiogram. How-
ever, until now, there has been no device capable of display-
ing, in real time, changes in these high frequency QRS com-
ponents in the monitored patient. While academic software
programs have been designed that analyze the central high
frequency QRS components, all such programs involve labo-
rious off-line calculations and post-processing, and therefore
have little if any clinical utility, being strictly research tools.
Thus, there remains a need for a system and method that
analyzes high frequency components over the entire QRS
interval inreal time for usefulness in the clinical environment.
Such a system should perform, in real time, all of the complex
digital sampling, averaging, and filtering that is required to
generate high frequency QRS ECG signals. The system
should also thereafter update these high frequency QRS ECG
signals, as well as other derived parameters, in real time on a
beat-to-beat basis, supplementing the diagnostic information
being obtained from the conventional (i.e. low frequency)
ECG complexes at the same time.
The higher frequency signals in the central portion of the
QRS ECG complex that have generated the most research
2
interest in terms of off-line detection of ischemia and infarc-
tion are those signals in the range of 150 to 250 Hz. The raw,
analog ECG signal is typically sampled at ?500 samples per
second (to digitize the signal) in order to adequately satisfy
5 the Nyquist rate of sampling at least twice the highest fre-
quency of interest and in order to retain the information in the
signal without loss. In the past, the sampled data have been
stored, and then later processed to provide potentially useful
information to the researcher.
10
On the other hand, Simpson, in U.S. Pat. No. 4,422,459,
teaches a system which analyzes only the late portion of the
QRS interval and early portion of the ST segment, and in an
off-line fashion (i.e. from previously stored data) to indicate
15 cardiac abnormalities, in particular the propensity for cardiac
arrhythmia. The late portion of a post myocardial infarct
patient's QRS waveform contains a high frequency (40-250
Hz) signal tail which is indicative of a tendency toward ven-
tricular tachycardia. The system in Simpson digitally pro-
20 cesses and filters a patient's QRS signals in a reverse time
manner to isolate the high frequency tail and avoid the filter
ringing which would otherwise hide the signal. Thus, in order
to do so, Simpson presupposes that the data are stored so that
they can be processed in reverse time order.
25 Albert et al. U.S. Pat. No. 5,117,833, partially focuses on
analyzing signals within the mid-portion of the QRS interval
for the indication of cardiac abnormality. The system of
Albert et al. uses a known technique ofbuilding up data points
to derive an average of heartbeat characteristics in order to
30 enhance signal to noise ratio. Data are collected and filtered
and then stored for subsequent analysis. Thus, the system
does not teach a cardiac monitor which provides the data
analysis immediately from the data derived from apatient, i.e.
in "real-time".
35 Albert et al., U.S. Pat. No. 5,046,504, similarly teaches the
acquisition of QRS data and subsequent analysis. Routine
calculations are performed from the data previously calcu-
lated and stored. Further, this system teaches producing a set
of digital spectrum values representative of an approximate
4o power density spectrum at each of a large number of generally
equally spaced sampling time intervals of the ECG wave-
form.
Seegobin, in U.S. Pat. Nos. 5,655,540 and 5,954,664, pro-
45 vides a method for identifying coronary artery disease. The
method relies on a database of high and low frequency ECG
data taken from known healthy and diseased subjects. Com-
parison of the data has led to a "Score" component, indicating
deviation of a patient's data from the norm. This reference is
50 rather calculation intensive, and does not suggest monitoring
the condition of a patient, but rather is utilized as an off-line
diagnostic tool.
Hutson, U.S. Pat. No. 5,348,020, teaches a technique of
near real-time analysis and display. The technique includes
55 inputting ECG data from multiple, sequential time intervals
and formatting those data into a two-dimensional matrix. The
matrix is then decomposed to obtain corresponding singular
values and vectors for data compression. The compressed
form of the matrix is analyzed and filtered to identify and
60 enhance ECG signal components of interest. As with other
systems, this reference focuses on late potentials, a fraction of
the QRS interval, as the tool to identify cardiac disease.
Finally, High-Frequency Electrocardiogram Analysis of
the Entire QRS in the Diagnosis and Assessment of Coronary
65 Artery Disease by Abboud (Progress in Cardiovascular Dis-
eases, Vol. XXXV, No. 5 (March/April), 1993: pp 311-328)
teaches the concept of "reduced amplitude zone" (RAZ) as a
US 7,539,535 B1
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diagnostic tool. However, this reference also uses post-pro-
cessing, and provides no teaching of a real-time analysis
system.
Thus, there remains a need for an electrocardiograph that
analyzes, in real time, the high frequency components of the
QRS complex in order to provide an effective monitor for
patients with specific cardiac function abnormalities. The
present invention is directed to such an electrocardiograph.
SUMMARY OF THE INVENTION
The present invention addresses these and other needs in
the art by providing a real time display of various aspects of
the QRS complex. The invention also provides a system for
such a display, and a method of displaying such aspects.
The present invention advances the state of the art by taking
high frequency electrocardiographic data immediately as
they are sensed from a patient, manipulating the data in con-
junction with the conventional low frequency signals, and
displaying the high frequency data in real time in a useful
form on a computer screen or monitor. In one aspect, the
invention displays the high frequency data from the QRS
complex in microvolts adjacent to a display of the conven-
tional ECG data in millivolts. In another aspect of the inven-
tion, the high frequency data are analyzed for their root mean
square (RMS) voltage values (as well as for related values
such as the high frequency energy (HFQE) and high fre-
quency integral of absolute value (HFAV), both described
hereinafter), with the discrete, lead-by-lead values being dis-
played in real time as useful diagnostic indicators for
ischemia. Also, the high frequency data from the QRS com-
plex are analyzed with imbedded algorithms to determine the
presence or absence of reduced amplitude zones, referred to
hereinafter as "RAZs". The given RAZ, of which there are at
least three possible variations (i.e., the `Abboud" RAZ, the
"NASA" RAZ, and the skewness-kurtosis or "S-K" RAZ, all
described below), is displayed as a real-time "go, no-go"
signal on the screen. Finally, in still another aspect of the
invention, not only the presence or absence any one of the
three variations of RAZs, but also the RMS and related values
(HFQE and HFAV) are displayed against time as time varying
signals.
In still another aspect of the invention, the electrocardio-
graph of this invention detects and aligns R-waves and QRS
complexes and analyzes these ECG signals after digitization
at high sampling rates of at least 500 samples per second, but
preferably at sampling rates of 1000 samples per second or
greater. The system also signal averages consecutive QRS
electrocardiographic complexes in a user-adjustable fashion
to increase the signal-to-noise ratio. The resulting averaged
signal is filtered, using non-recursive digital bandpass filters
with varying high and low frequency cutoffs, and displayed in
real time along with several other derived numerical measures
described herein including the power spectrum of the filtered
data. The resulting displays provide a clinician with real-time
information with respect to changes in the high frequency
ECG complex that may be indicative of myocardial ischemia,
myocardial infarction, or of changes in myocardial conduc-
tion that are unrelated to myocardial ischemia or infarction.
The invention includes a number of features that are neither
shown nor suggested in the art, including a real-time display
of cardiac electrical data that have been manipulated in such
a way as to provide a clear indication of ischemia and infarc-
tion. The invention further includes a number of user select-
able parameters to enhance the information provided to the
clinician. Finally, the invention provides a number of dis-
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plays, juxtaposed in real time, to provide a side-by-side com-
parison of various aspects of the QRS complex in real time.
These and other features of the invention will be apparent
to those of skill in the art from a review of the following
5 detailed description along with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG.1 is a schematic diagram of the overall system of this
10 invention.
FIG. 2 is a schematic diagram of a detail of FIG. 1.
FIG. 3 is a schematic diagram of the logic carried out by the
invention.
FIG. 4 is a real-time screen display, showing characteristic
15 data obtained from a healthy subject, including a side-by-side
display of a standard ECG and a filtered (high frequency)
ECG.
FIG. 5 is a real-time screen display, showing characteristic
data obtained from a patient having known cardiac disease,
20 including a side-by-side display of a standard ECG and a
filtered ECG.
FIGS. 6 and 7 are real-time screen displays, showing the
configuration of a QRS detector for a normal, healthy subject
and for a patient having known cardiac disease, respectively.
25 FIGS. 8 and 9 are real-time screen displays of cross corre-
lation between a running, continuously updated waveform, or
template, and a sensed waveform to determine departure from
the template from one heartbeat to the next.
FIGS. 10 and 11 are real-time screen displays of short term
30 trends of various data for a healthy subject and for a patient
having known cardiac disease, respectively.
FIGS. 12 and 13 are real-time screen displays of long term
trends of various data for a healthy subject and for a patient
having known cardiac disease, respectively
35 FIGS. 14 and 15 are real-time screen displays of high
frequency QRS skewness versus kurtosis for a healthy subject
and for a patient having known cardiac disease, respectively.
FIGS. 16 and 17 are real-time screen displays of the spec-
trum of power for normal and diseased patients, respectively.
40
DETAILED DESCRIPTION OF A PREFERRED
EMBODIMENT
FIG. 1 shows a simplified, functional, block diagram of a
45 real-time high frequency QRS electrocardiograph 10 con-
structed in accordance with the present invention. The inven-
tion monitors the cardiac function of a patient with a plurality
of patient electrodes 12. The electrodes provide measure-
ments of cardiac electrical function at various contact points
50 on the skin of a patient in the conventional manner. For
example, in the conventional 12-lead configuration, 10 elec-
trodes placed upon the skin of the patient in the conventional
configuration result in eight channels of incoming data. These
eight channels are in turn translated into 12 leads of data on
55 the patient monitor inasmuch as data for one of the bipolar
limb leads and for all of the augmented unipolar limb leads
can be derived if data for any two of the bipolar limb leads are
already known. The analog measurements are coupled to a
console 14 by way of a communications channel such as for
60 example a cable 13. The console components are shown in
greater detail in FIG. 2.
The console 14 conditions and digitizes the analog signal
and provides the digitized signal to a computer 16 by way of
a communications channel 15, which may preferably be a
65 conventional cable or a wireless communication channel by
radio frequency wave. The structure and function of the com-
puter is shown and described below in respect of FIG. 3. The
US 7,539,535 B1
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computer 16 is programmed to display the ECG signal in real 	 which are below the threshold set by the user (or set by the
time, although the ECG signal may also be stored on a digital 	 system default) are rejected, with block 52 accepting only
recording medium 18 over a communications channel 17 for 	 well-correlated beats to create the running templates. This
later display over a communications channel 17'. 	 feature helps to eliminate noisy, unreliable waveforms when
The computer 16 is coupled to a user interface 20 which 5 creating the running templates. From this block, the user
preferably includes communications devices 22 such as a	 interface displays a continuously updated running total of the
mouse, keyboard, and/or touch screen. The user interface	 number of beats accepted and rejected in block 51, a feature
further includes a monitor 24 for user controllable graphic	 of the invention.
display of the ECG and various aspects of the signal, a feature 	 Block 54 then aligns the beats by detecting and adjusting
of the present invention. The computer 16 is coupled to the io for any signal jitter, which may be created by any number of
interface 20 by way of bidirectional communications chan- 	 well-known factors, including minor inconsistencies in the
nels 19 and 19', for example. The aspects of the graphical 	 detection of the fiducial point, movement by the patient or
display are shown in greater detail and described below in 	 even respiration by the patient. The aligned, jitter-corrected
respect of FIGS. 4 through 17.	 waveform is then fed to block 56, a band-pass filter, prefer-
FIG. 2 depicts the structure of the console 14 in greater 15 ably 150-250 Hz, to select only the frequencies of interest in
detail. As previously described, the patient is wired with a set 	 the waveform. Finally, the band-pass signals are fed to block
of electrodes 12, such as for example a conventional set of ten 	 58, where, in the present embodiment, the eight channel to
electrodes for a 12-lead electrocardiograph to monitor car- 	 12-lead conversion is performed.
diac function from different aspects of the patient's body. The 	 From this point in the diagram of FIG. 3, blocks 62,64,68,
electrodes 12 provide a set of analog electrical signals to the 20 70, and 72 describe data which are displayed on the user
console 14, where they are received by a pre-amplifier 30 to	 interface 20, as shown in FIGS. 4 through 17. Block 62 shows
boost the amplitude of the weak ECG signals. The amplified 	 the instantaneous, real-time high frequency filtered QRS sig-
signals are then fed to an anti-aliasing filter 32. The filtered 	 nal for each lead, updating with each new beat as that beat is
signals are then fed to an analog to digital converter 34, where 	 incorporated into the average beat. Beats that are poorly
the signals are digitized at least the Nyquist rate, preferably 25 cross-correlated are rejected and thus the template averages
1,000 Hz or greater, to retain all of the information contained 	 and the display will not be altered by such beats. The display
in the analog signals. The sampled/digitized signals are then	 is shown by element number 114 in FIG. 4.
sent to the computer 16 by an appropriate medium 15.	 Block 64 determines the unfiltered QRS interval onset and
The operation of the computer 16 is depicted in FIG. 3. The 	 offset automatically and in real time. This block receives an
console 14 feeds the digitized ECG signals to the computer so input from block 54 which detected and adjusted for any jitter
via a communications channel 15, as previously described.	 in the well cross-correlated beats. The cross-correlation and
The computer 16 also interfaces with the user interface 20.	 jitter-correction from block 54 are therefore also displayed on
The computer 16 receives the ECG signals into a device driver 	 the user interface, as shown in FIGS. 8 and 9. Block 68
40, which is simply the interface device and program for the 	 describes the display of the instantaneous high frequency
console and computer. The device driver 40 provides the ECG 35 QRS RMS, HFQE and HFAV voltages and power spectrum
signals in parallel to an R-wave detection block 42 to syn-	 generated for each lead using the unfiltered QRS interval
chronize the system for the start of each heartbeat by locating 	 onset and offset, and shown in FIG. 4 as element numbers 116
the fiducial point. The following requirements must be met	 and 128.
for temporal averaging to work effectively. First, the signal of
	
Block 70 describes the running plots of the RAZs ("go/no-
interest must be repetitive and relatively invariable. Time 40 go") as well as the voltages for the RMS, HFQE and HFAV of
varying signals, such as ectopic or premature complexes, are 	 the high frequency QRS ECG signal versus time for each lead
eliminated before averaging by comparing incoming signals	 as depicted in FIGS. 10 through 13. FIGS. 10 (healthy sub-
against a previously established template through the use of a 	 ject) and 11 (subject with known coronary artery disease)
real-time cross-correlating technique. Second, the signal of
	
depict short-term data trends whereas FIGS. 12 (healthy sub-
interest must be timelocked to a fiducial point, such as near 45 ject) and 13 (subject with known coronary artery disease)
the peak of the QRS complex, that is easily detectable and 	 depict longer-term data trends. The horizontal (time) axis
serves as a timing reference forthe averaging algorithm. If the	 scale is user-adjustable on both the long and short-term trend
signal of interest does not have a fixed, temporal relationship	 plots, and can be shown either in beats (as depicted here) or in
with the timing reference point, the resultant averaged signal 	 seconds. Clinicians can utilize these trends to assess how a
will be filtered and distorted due to reference jitter, with 50 monitored patient's cardiac function has changed over time,
subsequent loss of the high frequency components. Third, the 	 up to and including the present time. Specifically, clinicians
signal of interest and the noise must be independent and	 can identify whether and when RAZs have developed or
remain independent during averaging. 	 disappeared during the period of monitoring, as well the
Once the fiducial point has been located for each incoming 	 degree to which the RMS and related voltages of the high
beat, the digitized signals are fed to block 44 where initial 55 frequency QRS complex have changed over the same period
templates of the QRS complexes are generated. The present 	 of monitoring. Realization of such changes is particularly
invention includes running signal averages of the QRS com- 	 valuable to clinicians during situations when the presence or
plexes that constitute templates, with the number of indi- 	 absence of incipient myocardial ischemia or infarction needs
vidual beats in the running templates being selectable by the 	 to be immediately identified, when the success or failure of
user on the user interface 20. The user can also determine the 60 invasive or noninvasive treatments administered for ischemia
percent of cross -correlation between each new incoming beat 	 and infarction needs to be immediately recognized, and/or
and the templates which will be detected as a departure from 	 when cardiovascular responses during pharmacological or
the norm, and which channel(s) that will be used for the 	 exercise stress tests or during apatient's ambulatory activities
cross-correlation functions.	 needs to be assessed.
With the user-selected inputs as just described, the system 65	 Finally, block 72 describes another feature of the invention,
in block 48 runs a real-time cross-correlation function on	 online instantaneous RAZ detection for each lead. The pres-
each subsequent incoming beat. In block 50, those beats	 ence of a "RAZ", or "reduced amplitude zone" within the
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envelope of the averaged high-frequency QRS signal, may be
an indication of abnormal cardiac function. A RAZ, as origi-
nally defined by Abboud (but only in the context of off-line
analyses), classically occurs when at least two local maxima
of the upper envelope or two local minima of the lower
envelope are present within the high frequency QRS signal. A
local maximum or minimum is in turn defined as an envelope
sample point (peak or trough) within the QRS interval
wherein the absolute value of its voltage exceeds that of the
three envelope sample peaks immediately preceding and fol-
lowing it. The RAZ is thus the region lying between the two
neighboring maxima or minima. The present invention per-
forms a real-time calculation, looking for local maxima and
minima of the QRS envelope not only according to previously
published off-line criteria of Abboud (i.e., "RAZ,", or the
Abboud RAZ) but also separately and especially according to
new criteria that improve the specificity and accuracy of RAZ
detection, particularly for the online setting.
One especially important modification contributing to such
improvement is the requirement that the second, smaller local
maximum within the high frequency QRS signal that defines
the presence of the RAZ be at least two times, and optionally
up to three to four times, larger in amplitude than the RMS
"noise" of the high frequency signal that is present outside of
the QRS interval (i.e., in any given chosen segment within the
PR, ST or TP intervals). Another modification criterion
implemented optionally by the user into the online RAZ
detector is that the absolute value of the amplitude of the
smaller of the two local maxima (or minima) constituting the
RAZ must be at least a certain percentage of that of the larger
of the two local maxima (or minima). These modifications as
optionally implemented by the user within the present inven-
tion, together with the requirement that at least two local
maxima of the upper envelope "and" (rather than "or") two
local minima of the lower envelope be present to constitute a
RAZ, are collectively referred to as the criteria that define the
"NASA RAZ", or "RAZA '.
Yet another novel set of user-selectable criteria used in the
present invention to assess the presence or absence of a "sta-
tistical" type of RAZ concerns the use of real-time calculation
of the both the skewness and the kurtosis of the incoming high
frequency QRS signal. When present, the skewness-kurtosis
type of RAZ is referred to as the RAZ,-K. The presence of a
RAZ,, RAZr„ and/or RAZSK by "go/no-go" indicators on
the display, as shown by element 117 in FIG. 4, may also be
displayed as a running parameter with time, in a manner
similar to FIGS. 10-13.
Referring now more particularly to FIGS. 4 and 5, a feature
of the present invention is the simultaneous display in real-
time of various aspects of cardiac function with respect to
both the conventional and high frequency QRS ECG. Further,
the present invention provides simultaneous, side-by-side or
vertical displays of that data to provide the clinician with a
tool to compare these aspects of the ECG with one another for
a more complete picture of cardiac function than has been
previously available. The present invention also displays the
conventional and high frequency 12-lead configurations on
one user interface display, while displaying the presence or
absence of RAZs on the same display to alert the clinician to
potentially abnormal cardiac function.
The display of FIGS. 4 and 5 includes a conventional, low
frequency ECG signal, designated by the element number
112. The display signal 112 includes the signals from leads L,
II, III, aVR, aVL, aVF, and V1-V6 in the conventional man-
ner. Further, the display signal 112 slides from left to right,
updated with each beat, also in the conventional manner, as a
reference for the clinician. Positioned immediately adjacent
8
to orbelow the conventional ECG display 112 is a display 114
of a running, instantaneous filtered (i.e. high frequency) QRS
ECG signal, one for each of the twelve leads, corresponding
to the individual leads of the display 112. The display signal
5 114 includes the signals from leads I, II, III, aVR, aVL, aVF,
and V1-V6 to correspond to like signals in the display 112.
Above each high frequency QRS signal is the instantaneous
RMS value 116 in that particular lead, and an instantaneous
RAZ indicator 117, defaulted to the RAZ type of the user's
l0 
choice (in this case the RAZ, ).
At the bottom of the screen display of FIGS. 4 and 5 is a
tool bar 120. The tool bar 120 provides user control and
display of various data useful to the clinician. The tool bar
15 includes a user selectable indicator 122 in which the user can
select which of a plurality of QRS complexes to capture.
Displays 124,126, and 128 show the timing of the QRS onset,
QRS offset, and the duration of the QRS complex, respec-
tively. A display 130 shows the total number of heartbeats
20 which have been detected during any particular run, while a
display 132 shows the number of beats rejected and a display
134 shows the number of beats whose processing is pending,
if any. Toggle buttons 136 and 138 permit the user to turn on
and turn off the cross correlation function and the beat rejec-
25 tion function, respectively. Display buttons 140, 142, 144,
and 146 permit the user to select other displays for the screen,
as shown. A toggle button 148 permits the user to turn on and
turn off an autoscale function, and a print button 148 permits
the user to print a particular screen capture at his discretion.
30 Of particular note, in comparing FIGS. 4 and 5, is the small
number of reduced amplitude zones and lit RAZ indicators
117 for the healthy patient shown in FIG. 4, versus the much
larger number of reduced amplitude zones and lit RAZ indi-
cators for the subject with known coronary artery disease,
35 shown in FIG. 5.
FIGS. 6 and 7 show configuration screen 160 for the online
QRS interval detector of the invention, selectable by button
146 of FIGS. 4 and 5. The configuration screen of FIGS. 6 and
40 7 permits the user to select a period within the P-R interval of
the ECG, with specific pre-Q offset and interval width selec-
tors 162 and 164, respectively, that will aid in the determina-
tion of the onset of the QRS complex. The values for these
parameters shown in FIGS. 6 and 7 have been selected based
45 on initial experience to provide satisfactory performance of
the invention for the broadest array of subjects, since cardiac
function typically varies from patient to patient. Similarly,
selectors 166 and 168 permit the user to select the offset and
width, respectively, of a portion of the ST segment that will
50 aidinthe determination ofthe offset ofthe QRS complex. The
configuration screen 160 also displays various parameters
measured from the current heartbeat, as shown. An indicator
170 shows the user which of the leads is selected, in the case
of FIGS. 6 and 7 that lead is lead II. A RAZ indicator 117 is
55 also provided for the convenience of the user.
FIGS. 6 and 7 also include superimposed displays of a low
frequency signal averaged ECG 172 and an averaged high
frequency filtered signal 174. The ordinate on the left of
FIGS. 6 and 7 shows the averaged low frequency signal 172 in
60 millivolts, and the ordinate on the right shows the averaged
high frequency signal 174 in microvolts.
FIG. 6 shows a single local maximum 176 and a single
local minimum 178. However, FIG. 7, depicting the wave-
forms for a patient with known coronary artery disease, shows
65 two local maxima 180 and 182, and two local minima 184 and
186. Since the maxima and/or minima occur within the QRS
complex, and are separated by at least three envelope sample
US 7,539,535 B1
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points with lesser absolute amplitudes between them, they
define a reduced amplitude zone as also shown on the lit RAZ
indicator 117.
FIGS. 8 and 9 depict cross correlation screens 190 of the
invention. The screen 190 is selected by a user with button
144 (FIG. 4). The screen includes a display 192 of a template,
averaged over a user selectable number of beats. A display
194 shows the low frequency ECG of the current beat, and a
display 196 shows the cross correlation between the wave-
forms of display 192 and display 194. A user may select the
threshold for the cross correlation, below which the beat is
rejected, by a selector 197 and, if a beat is rejected, an indi-
cator light 198 illuminates.
Note that in FIG. 9 the current heartbeat shown on the
display 194 is noisy and has a different shape than the tem-
plate. The current beat is also shifted in time from the tem-
plate of display 192. Consequently, the cross correlation
between them is poor, as reflected in the display 196, which
only has a peak of 0.951 (i.e. below the user selectable thresh-
old set at 0.970 in this case) and the beat is rejected, as shown
by the indicator light 198. Thus, the current beat is not incor-
porated into the running template of the averaged ECG.
FIGS. 10 through 13 depict trend lines for the RMS,
HFQE, and HFAV, as well as show the current value for these
parameters. These displays further include lines depicting the
presence versus the absence of three types of RAZ as
described herein. These displays illustrate another feature of
the present invention, that of showing a trend of parameters
overtime. Specifically, the trend lines shown on a screen 200,
which are continuously updated in real time, illustrate the
presence (versus the absence) of all three types of RAZs over
a user-selectable period of time (always up to and including
the present time) as well as the voltage trends for RMS, HFQE
and HFAV over this same user-selectable period of time for all
the leads attached to the patient. FIGS. 10 and 11 provide
examples of trend lines on a short-term time scale for a
healthy subject and for a patient with known coronary artery
disease, respectively, whereas FIGS. 12 and 13 provide cor-
responding examples of trend lines on a long-term time scale
for these same individuals. The short and long-term trend line
plots can be accessed simultaneously by the user, and, to
reiterate, the time intervals (horizontal axes depicted here in
units of beats) on both plots are completely selectable by the
user. The particular parameters depicted on these plots are
intended to be illustrative only, and other parameters may be
similarly illustrated. The ordinate for each plot is in micro-
volts with respect to the RMS, BFQE and HFAV (the RAZs
are unitless, "go versus no-go" entities), whereas the abscissa
can be in either beats or seconds, for characterization of the
trend.
Numerical measures of the high frequency QRS ECG may
be calculated in several ways. These measures are important
because they often decrease when ischemia is present. Per-
haps the most popularmeasure is the root mean square (RMS)
voltage of the QRS signal, which is equivalent to the "area
under the curve" of the power spectrum, defined as
f9 jf
°Y_ Xz
RMS =
	
jgon
UFQRSD
where X, is the filtered voltage at a given sampling point,
ufqon and ufqoff are the onset and offset, respectively, of the
QRS interval, and UFQRSD is the unfiltered QRS interval
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duration as defined by ufqon and ufqoff. In this context, the
term "onset' means the start of the QRS interval, and the term
"offset" means the end of the QRS interval. This is the pri-
mary numerical measure used in preferred embodiment of the
5 present invention.
Other numerical measures of the high frequency QRS sig-
nal have also been proposed (and used strictly in an off-line
fashion) by Xue et al. (see Xue, Q., B. R. Reddy, and T.
io Aversano. Analysis of high-frequency signal-averaged ECG
measurements. J Electrocardiol 28: 23945, 1995). These
numerical measures include the high frequency integral of
absolute values (HFAV) and the high frequency QRS energy
15 (HFQE). Xue et al. have defined HFAV and HFQE as follows:
ugojj+10m
HFAV = Y^ IX; — AVNLI
i—q —10ms
20
and,
25	 goff+10m
HFQE _ Z (X; — AVNL)'
i—q —10ms
30 wherein AVNL equals the average noise level of the filtered
signal in the ST segment in a 40 ms window located 60 ms
from the QRS offset. It should be noted that in their own
definitions for HFAV and HFQE (as shown above), Xue et al.
"pad" both the QRS onset and offset by extra 10 ms each in an
35 effort to reduce noise and noise variability, presumably to
compensate for potential inaccuracies and inconsistencies
related to the determination of the QRS interval.
In the presently preferred embodiment of the present
40 invention, the definitions for HFAV and HFQE are modified
in two ways. First, because the present invention provides a
means of viewing the high and low frequency ECG signal in
real time, thereby providing reliability for the determination
of the QRS interval, the necessity (or lack thereof) of using
45 the 10 millisecond padding periods is left to the discretion of
the user. Second, the present invention preferably uses the PR
interval or TP segment rather than the ST segment to deter-
mine the AVNL of the baseline, since a segment of the cardiac
cycle wherein neither depolarization nor repolarization is
50 present is preferred. In the device of the present invention
disclosed herein, AVNL is determined as the RMS noise of
the filtered signal that is within a 25 ms interval in the PR
segment.
55 In the preferred embodiment, HFAV is measured as:
ugojj
HFAV = Y. IX; —AVNLI
i=uq-
60
whereinAVNL (average noise level) equals the "noise" of the
high frequency (i.e., filtered) signal within that portion of the
65 PR interval just noted.
Further, high frequency QRS energy (HFQE) is calculated
as:
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HFQE = Y.
 (X; - AVNL)'
i=uq-
wherein AVNL is determined in the same way as for HFAV.
A useful characterization of a set of data includes skewness
and kurtosis. Skewness is a measure of symmetry, or more
accurately, the lack of symmetry. A distribution, or data set, is
symmetric if it looks the same to the left and right of the center
point. Kurtosis is a measure of whether the data are peaked or
flat relative to a normal distribution. That is, data sets with a
high kurtosis tend to have a distinct peak near the mean,
decline ratherrapidly, andhave heavy tails. Data sets with low
kurtosis tend to have a flat top near the mean rather than a
sharp peak. A uniform distribution would be the extreme case.
By displaying skewness values alone, kurtosis values alone,
or skewness versus kurtosis graphically with one value on the
ordinate and the other on the abscissa, the clinician may
obtain information from the high frequency QRS signals
potentially indicative of cardiac disease. Referring to FIGS.
14 and 15, a display 250 is provided to show real-time, con-
tinuously updated plots of skewness versus kurtosis against a
background line of a normal population distribution function.
If a patient's S-K data in any given lead fall on or above that
lead's distribution function, the data for that lead are consid-
ered "normal", as shown in most of the leads of FIG. 14,
whereas data from any given lead falling below that lead's
distribution function, as shown in most of the leads of FIG.
15, provides a visual indication of potential cardiac disease,
i.e., a positive "RAZs
-x7'•
Referring now to FIGS. 16 and 17, a display 270 is pro-
vided to show the power spectrum of the high frequency QRS
signal for each lead. A change in the shape of the spectral plot
such that two distinct peaks occur rather than one may be
further indication of cardiac malfunction.
The principles, preferred embodiment, and mode of opera-
tion of the present invention have been described in the fore-
going specification. This invention is not to be construed as
limited to the particular forms disclosed, since these are
regarded as illustrative rather than restrictive. Moreover,
variations and changes may be made by those skilled in the art
without departing from the spirit of the invention.
We claim:
1. A process of operating a computer, comprised of a gen-
eral purpose data processor of known type and a display
device, to enable the data processor to execute a plurality of
steps in an object program, such that the same results will be
produced when using the same given data, comprising the
steps of
a. inputting a patient's electrocardiograph signal to the
computer via a communications channel, the signal
comprising a succession of waves;
b. using the data processor to independently isolate the
QRS interval from each of the waves of the signal;
c. using the data processor to independently analyze data
within each of the isolated
QRS intervals relating to cardiac function of a patient in
real-time, the step of analyzing including band-pass fil-
tering the data between about 150 Hz and about 250 Hz;
and
d. using the display device to display the analyzed data, the
signal, the waves of the signal, the QRS intervals, or any
combination beat-by-beat in real-time.
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2. The process of claim 1, wherein the step of analyzing the
data within the QRS interval further comprises the steps of
using the data processor to generate an initial template of
the signal using the first QRS interval from the first wave
5	 of the signal;
using the data processor to cross-correlate each subsequent
independently isolated QRS interval against predeter-
mined criteria wherein accepted QRS intervals are
incorporated into the initial template to create a running
10	 template in real-time;
using the data processor to align each independently iso-
lated QRS interval with the running template in real-
time; and
using the data processor to calculate predetermined, select-
15	 able characteristics of each QRS interval in a beat-by-
beat, real-time manner.
3. The process of claim 2, wherein the step of using the data
processor to calculate is comprised of calculating a reduced
amplitude zone,
20 wherein the reduced amplitude zone occurs when at least
two local maxima or at least two local minima are
present in the filtered data; and
wherein each local maximum or each local minimum is a
peak or a trough, respectively and wherein the absolute
25 value of each peak or trough's voltage exceeds that of a
predetermined number of sample points within the fil-
tered data immediately preceding and following each
peak or trough.
4. The process of claim 3, wherein the absolute value of the
so amplitude of the smallest of the at least two local maxima or
the smallest of the at least two minima is at least a predeter-
mined percentage relative to the largest of the at least two
maxima or the largest of the at least two minima, respectively.
5. The method of claim 3, wherein the absolute value of the
35 amplitude of the smallest of the at least two local maxima or
the smallest of the at least two local minima is at least a
predetermined multiple of the high frequency noise level of a
predetermined iso-electric portion.
6. The method of claim 2, wherein the step of using the data
40 processor to calculate is comprised of calculating a skewness,
kurtosis, or both of the filtered data.
7. The process of claim 1, wherein the step of using the data
processor to independently analyze is further comprised of
using the data processor to compute the presence or absence
45 of reduced amplitude zones from the high frequency filtered
data associated with the QRS interval.
8. A process of operating a computer, comprised of a gen-
eral purpose data processor of known type, to enable the data
processor to execute a plurality of steps in an object program,
50 such that the same results will be produced when using the
same given data, comprising the steps of
a. inputting a patient's electrocardiograph signal to the
computer via a communications channel, the signal
comprising a succession of waves;
55	 b. using the data processor to independently isolate the
QRS interval from each of the waves of the signal;
c. using the data processor to independently analyze data
within each of the QRS intervals relating to cardiac
function of a patient in real-time, the step of analyzing
60	 including band-pass filtering the data between about 150
Hz and about 250 Hz;
d. connecting a storage device to the data processor; and
e. using the storage device to store the analyzed data, the
signal, the waves of the signal, the QRS intervals, or any
65	 combination.
9. An electronic storage database of the analyzed data, the
signal, the waves of the signal, the QRS intervals, or any
US 7,539,535 B1
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combination resulting from the process described in claim 8
wherein the database is stored in the storage device.
